TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T52522	Adrenergic receptor beta-2	D07MOX	Norepinephrine	Approved	439260	C8H11NO3	169.18	C1=CC(=C(C=C1[C@H](CN)O)O)O	Ki = 96700 nM	Poor binder
T52522	Adrenergic receptor beta-2	D0G8NN	Pramipexole	Approved	119570	C10H17N3S	211.33	CCCN[C@H]1CCC2=C(C1)SC(=N2)N	Ki = 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	D0T7OW	Dopamine	Approved	681	C8H11NO2	153.18	C1=CC(=C(C=C1CCN)O)O	Ki = 61000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B0BCT7	4-[1-Hydroxy-2-[[4-[[[2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl]amino]methyl]phenyl]methylamino]ethyl]-2-(hydroxymethyl)phenol	Investigative	54417230	C26H32N2O6	468.5	C1=CC(=CC=C1CNCC(C2=CC(=C(C=C2)O)CO)O)CNCC(C3=CC(=C(C=C3)O)CO)O	IC50 = 50118.72 nM	Poor binder
T52522	Adrenergic receptor beta-2	B0F7HP	(+/-)-N-[5-(2-Bromo-1-hydroxyethyl)isoxazol-3-yl]methanesulfonamide	Investigative	44423639	C10H19N3O4S	277.34	CC(C)(C)NCC(C1=CC(=NO1)NS(=O)(=O)C)O	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B0QK9M	Chembl4204907	Investigative	145978746	C14H15F3N2S	300.34	CC(CC(F)(F)F)NCC1=CC=C(C=C1)C2=NC=CS2	Ki = 52300 nM	Poor binder
T52522	Adrenergic receptor beta-2	B0SEC1	4-[2-[[(2R)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]-N-phenylbenzenesulfonamide;hydrochloride	Investigative	49861319	C23H27ClN2O4S	463	C1=CC=C(C=C1)NS(=O)(=O)C2=CC=C(C=C2)CCNC[C@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B1B3IC	N-[4-[2-[[(2S)-2-Hydroxy-3-[4-(methanesulfonamido)phenoxy]propyl]amino]ethyl]phenyl]-2-pyridin-2-ylacetamide	Investigative	44574685	C25H30N4O5S	498.6	CS(=O)(=O)NC1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CC=CC=N3)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B1JE0V	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(3-nitrophenyl)thiourea;hydrochloride	Investigative	49861307	C24H27ClN4O4S	503	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC(=CC=C3)[N+](=O)[O-])O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B1YC8S	1-(2-Chlorophenyl)-3-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]thiourea;hydrochloride	Investigative	73352659	C24H27Cl2N3O2S	492.5	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=CC=C3Cl)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B23IMZ	N-[4-[2-[[(2S)-2-Hydroxy-3-[(2-oxo-1,3-dihydrobenzimidazol-4-yl)oxy]propyl]amino]ethyl]phenyl]-2-pyridin-2-ylacetamide	Investigative	44574688	C25H27N5O4	461.5	C1=CC=NC(=C1)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC4=C3NC(=O)N4)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B23XSU	Chembl4159562	Investigative	145960116	C21H30ClN3O5S	472	CCCNCC(COC1=CC=C(C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B2F7SX	3-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione	Investigative	4013695	C23H25N5O3	419.5	COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B2FL1Q	5-[(1S)-2-[[(2R)-Heptan-2-yl]amino]-1-hydroxyethyl]benzene-1,3-diol	Investigative	16737587	C15H25NO3	267.36	CCCCC[C@@H](C)NC[C@H](C1=CC(=CC(=C1)O)O)O	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B2TBZ5	2-Amino-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-phenylacetamide	Investigative	44127478	C25H29N3O4	435.5	C1=CC=C(C=C1)C(C(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=C(C=C3)O)O)N	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B2XGK8	3-[2-[4-Phenyl-1-piperazinyl]ethyl]-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione	Investigative	15054187	C22H23N5O2	389.4	C1CN(CCN1CCN2C(=O)C3=C(C4=CC=CC=C4N3)NC2=O)C5=CC=CC=C5	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B2ZX4C	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-(4-methoxyphenyl)acetamide	Investigative	44127054	C26H30N2O5	450.5	COC1=CC=C(C=C1)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=C(C=C3)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B31CSQ	(4-{(R)-2-[(R)-2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-propyl}-phenoxymethyl)-methyl-phosphinic acid	Investigative	44286980	C19H25ClNO4P	397.8	C[C@H](CC1=CC=C(C=C1)OCP(=O)(C)O)NC[C@@H](C2=CC(=CC=C2)Cl)O	Ki = 73700 nM	Poor binder
T52522	Adrenergic receptor beta-2	B35VLG	(S,S)-(+)-5-[1-Hydroxy-2-(1-methylhexylamino)ethyl]-1,3-benzenediol	Investigative	44424581	C14H23NO3	253.34	CCCC[C@H](C)NC[C@H](C1=CC(=CC(=C1)O)O)O	Ki = 56234.13 nM	Poor binder
T52522	Adrenergic receptor beta-2	B3KL5A	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(2-methoxyphenyl)thiourea;hydrochloride	Investigative	49861312	C25H30ClN3O3S	488	COC1=CC=CC=C1NC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B43TUH	N-[4-[2-[[(2S)-2-Hydroxy-3-pyridin-3-yloxypropyl]amino]ethyl]phenyl]-2-pyridin-2-ylacetamide	Investigative	44574687	C23H26N4O3	406.5	C1=CC=NC(=C1)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CN=CC=C3)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B47VLT	Disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate	Investigative	5312115	C20H18ClNNa2O7	465.8	C[C@H](CC1=CC2=C(C=C1)OC(O2)(C(=O)[O-])C(=O)[O-])NC[C@@H](C3=CC(=CC=C3)Cl)O.[Na+].[Na+]	Ki = 79200 nM	Poor binder
T52522	Adrenergic receptor beta-2	B4AF6R	N-[4-[2-[[(2S)-3-(9H-Carbazol-4-yloxy)-2-hydroxypropyl]amino]ethyl]phenyl]-2-pyridin-2-ylacetamide	Investigative	44574720	C30H30N4O3	494.6	C1=CC=C2C(=C1)C3=C(N2)C=CC=C3OC[C@H](CNCCC4=CC=C(C=C4)NC(=O)CC5=CC=CC=N5)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B4Y1JZ	(S)-1-[(2-{1-[(1-Benzylimidazol-2-yl)acetyl]-1,2,3,4-tetrahydroquinolin-6-yl}ethyl)-amino]-3-phenoxy-2-propanol	Investigative	44574978	C32H36N4O3	524.7	C1CC2=C(C=CC(=C2)CCNC[C@@H](COC3=CC=CC=C3)O)N(C1)C(=O)CC4=NC=CN4CC5=CC=CC=C5	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B57BPY	1-Cyclohexyl-3-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]thiourea;hydrochloride	Investigative	49861306	C24H34ClN3O2S	464.1	C1CCC(CC1)NC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B5BOX7	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-quinolin-2-ylacetamide	Investigative	44127677	C28H29N3O4	471.5	C1=CC=C2C(=C1)C=CC(=N2)CC(=O)NC3=CC=C(C=C3)CCNC[C@@H](COC4=CC=C(C=C4)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B5I4HU	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-naphthalen-1-ylacetamide	Investigative	44127782	C29H30N2O4	470.6	C1=CC=C2C(=C1)C=CC=C2CC(=O)NC3=CC=C(C=C3)CCNC[C@@H](COC4=CC=C(C=C4)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B5MFA3	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-phenylacetamide	Investigative	44127681	C25H28N2O4	420.5	C1=CC=C(C=C1)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=C(C=C3)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B5P1MC	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2,2-diphenylacetamide	Investigative	44126931	C31H32N2O4	496.6	C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)NC3=CC=C(C=C3)CCNC[C@@H](COC4=CC=C(C=C4)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B5Q8IK	Methyl 4-[[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]carbamothioylamino]benzoate;hydrochloride	Investigative	49861315	C26H30ClN3O4S	516.1	COC(=O)C1=CC=C(C=C1)NC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B5S6KG	N-[4-[2-[[(2S)-2-Hydroxy-3-(1H-indol-4-yloxy)propyl]amino]ethyl]phenyl]-2-pyridin-2-ylacetamide	Investigative	44574651	C26H28N4O3	444.5	C1=CC=NC(=C1)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC4=C3C=CN4)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B5XK3R	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-(2-methoxyphenyl)acetamide	Investigative	44127052	C26H30N2O5	450.5	COC1=CC=CC=C1CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=C(C=C3)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B68VON	3-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl]-1,5-dimethylpyrimido[5,4-b]indole-2,4-dione	Investigative	3416533	C25H29N5O3	447.5	CN1C2=CC=CC=C2C3=C1C(=O)N(C(=O)N3C)CCN4CCN(CC4)C5=CC=CC=C5OC	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B6UA3Q	2-Hydroxy-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-phenylacetamide	Investigative	44127048	C25H28N2O5	436.5	C1=CC=C(C=C1)C(C(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=C(C=C3)O)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B6VCO2	N-[6-(6,7-Dihydroxy-1,2,3,4-tetrahydro-isoquinolin-1-ylmethoxy)-naphthalen-2-yl]-4-(3-hexyl-ureido)-benzenesulfonamide	Investigative	9896742	C33H38N4O6S	618.7	CCCCCCNC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC3=C(C=C2)C=C(C=C3)OCC4C5=CC(=C(C=C5CCN4)O)O	IC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B71NQZ	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-phenylurea;hydrochloride	Investigative	52949022	C24H28ClN3O3	441.9	C1=CC=C(C=C1)NC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B72KWT	5-[(R)-1-Hydroxy-2-[[(alphaS)-alpha-propyl-4-methoxyphenethyl]amino]ethyl]resorcinol	Investigative	73057082	C20H27NO4	345.4	CCC[C@@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=CC(=C2)O)O)O	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B7I8XR	1-(4-Chlorophenyl)-3-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]thiourea;hydrochloride	Investigative	73357212	C24H27Cl2N3O2S	492.5	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=C(C=C3)Cl)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B7K8OE	N-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-2-pyridin-2-ylacetamide	Investigative	44574686	C24H27N3O3	405.5	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CC=CC=N3)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B7KS3F	5-[(1S)-2-[[(2S)-Heptan-2-yl]amino]-1-hydroxyethyl]benzene-1,3-diol	Investigative	16735276	C15H25NO3	267.36	CCCCC[C@H](C)NC[C@H](C1=CC(=CC(=C1)O)O)O	Ki = 56420 nM	Poor binder
T52522	Adrenergic receptor beta-2	B7XCG9	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-pyrazin-2-ylacetamide	Investigative	44127679	C23H26N4O4	422.5	C1=CC(=CC=C1CCNC[C@@H](COC2=CC=C(C=C2)O)O)NC(=O)CC3=NC=CN=C3	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B81LBV	5-[(R)-1-Hydroxy-2-[[(alphaS)-alpha-isopropyl-4-methoxyphenethyl]amino]ethyl]resorcinol	Investigative	73056755	C20H27NO4	345.4	CC(C)[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=CC(=C2)O)O)O	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B8B6OC	2-(1-Benzylimidazol-4-yl)-N-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]acetamide	Investigative	44574826	C29H32N4O3	484.6	C1=CC=C(C=C1)CN2C=C(N=C2)CC(=O)NC3=CC=C(C=C3)CCNC[C@@H](COC4=CC=CC=C4)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B8EPO9	Chembl4173735	Investigative	145951865	C15H26ClN3O4S	379.9	CNCC(COC1=CC=C(C=C1)S(=O)(=O)N2CCN(CC2)C)O.Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B8MFZ3	2-(2-Chlorophenyl)-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]acetamide	Investigative	44127050	C25H27ClN2O4	454.9	C1=CC=C(C(=C1)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=C(C=C3)O)O)Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B8PC9R	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(2-nitrophenyl)thiourea;hydrochloride	Investigative	49861311	C24H27ClN4O4S	503	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=CC=C3[N+](=O)[O-])O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B9K3NX	N-[3'-(6,7-Dihydroxy-1,2,3,4-tetrahydroisoquinoline-1-ylmethyl)-4-biphenylyl]-4-(3-hexylureido)benzenesulfonamide	Investigative	9962058	C35H40N4O5S	628.8	CCCCCCNC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)C3=CC=CC(=C3)CC4C5=CC(=C(C=C5CCN4)O)O	IC50 = 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B9PSC5	1-(4-Fluorophenyl)-3-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]thiourea;hydrochloride	Investigative	49861317	C24H27ClFN3O2S	476	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=C(C=C3)F)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B9RSQ0	Chembl4208846	Investigative	145966568	C20H20F4N2O2	396.4	CN1C=C(C2=C1C=CC(=C2)OC)CCNCC3=C(C=CC(=C3)OC(F)(F)F)F	Ki = 80400 nM	Poor binder
T52522	Adrenergic receptor beta-2	B9VNC2	N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[5-(3-oxo-3-pyrrolidin-1-yl-propyl)-[1,2,4]oxadiazol-3-yl]-benzenesulfonamide	Investigative	44280957	C30H34N6O5S	590.7	C1CCN(C1)C(=O)CCC2=NC(=NO2)C3=CC=C(C=C3)S(=O)(=O)NC4=CC=C(C=C4)CCNC[C@@H](C5=CN=CC=C5)O	IC50 = 51000 nM	Poor binder
T52522	Adrenergic receptor beta-2	B9WQB5	2-(3-Chlorophenyl)-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]acetamide	Investigative	44127479	C25H27ClN2O4	454.9	C1=CC(=CC(=C1)Cl)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=C(C=C3)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BA0FL8	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(4-iodophenyl)thiourea;hydrochloride	Investigative	49861318	C24H27ClIN3O2S	583.9	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=C(C=C3)I)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BAR3X7	N-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-2-(1-phenylimidazol-2-yl)acetamide	Investigative	44574759	C28H30N4O3	470.6	C1=CC=C(C=C1)N2C=CN=C2CC(=O)NC3=CC=C(C=C3)CCNC[C@@H](COC4=CC=CC=C4)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BAYW36	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-thiophen-3-ylacetamide	Investigative	44127056	C23H26N2O4S	426.5	C1=CC(=CC=C1CCNC[C@@H](COC2=CC=C(C=C2)O)O)NC(=O)CC3=CSC=C3	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BB8V0U	1-(3-Chlorophenyl)-3-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]thiourea;hydrochloride	Investigative	73349644	C24H27Cl2N3O2S	492.5	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC(=CC=C3)Cl)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BB9Z8E	2-(4-Chlorophenyl)-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]acetamide	Investigative	44127480	C25H27ClN2O4	454.9	C1=CC(=CC=C1CCNC[C@@H](COC2=CC=C(C=C2)O)O)NC(=O)CC3=CC=C(C=C3)Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BC1JZ3	N-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-2-(6-phenylmethoxypyridin-2-yl)acetamide	Investigative	44574757	C31H33N3O4	511.6	C1=CC=C(C=C1)COC2=CC=CC(=N2)CC(=O)NC3=CC=C(C=C3)CCNC[C@@H](COC4=CC=CC=C4)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BC41NO	(S,R)-(+)-5-[1-Hydroxy-2-(1-methylhexylamino)ethyl]-1,3-benzenediol	Investigative	44424580	C14H23NO3	253.34	CCCC[C@@H](C)NC[C@H](C1=CC(=CC(=C1)O)O)O	Ki = 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BC6EX5	N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[5-(naphthalen-2-yloxymethyl)-[1,2,4]oxadiazol-3-yl]-benzenesulfonamide	Investigative	44281372	C34H31N5O5S	621.7	C1=CC=C2C=C(C=CC2=C1)OCC3=NC(=NO3)C4=CC=C(C=C4)S(=O)(=O)NC5=CC=C(C=C5)CCNC[C@@H](C6=CN=CC=C6)O	IC50 = 90000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BC8I2Y	4-[(S)-2-Hydroxy-3-[1-(3,4-dimethoxyphenylsulfonyl)-4-piperidinylamino]propoxy]-9H-carbazole	Investigative	9915235	C28H33N3O6S	539.6	COC1=C(C=C(C=C1)S(=O)(=O)N2CCC(CC2)NC[C@@H](COC3=CC=CC4=C3C5=CC=CC=C5N4)O)OC	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BC9Q3S	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-phenylthiourea;hydrochloride	Investigative	49861310	C24H28ClN3O2S	458	C1=CC=C(C=C1)NC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BD40VI	3-[2-[4-(4-Methoxyphenyl)-1-piperazinyl]ethyl]-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione	Investigative	15054190	C23H25N5O3	419.5	COC1=CC=C(C=C1)N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BD5Y8T	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-pyridin-4-ylacetamide	Investigative	44127374	C24H27N3O4	421.5	C1=CC(=CC=C1CCNC[C@@H](COC2=CC=C(C=C2)O)O)NC(=O)CC3=CC=NC=C3	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BE0WR5	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(4-nitrophenyl)thiourea;hydrochloride	Investigative	44517691	C24H27ClN4O4S	503	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=C(C=C3)[N+](=O)[O-])O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BE89CD	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-naphthalen-2-ylacetamide	Investigative	44126933	C29H30N2O4	470.6	C1=CC=C2C=C(C=CC2=C1)CC(=O)NC3=CC=C(C=C3)CCNC[C@@H](COC4=CC=C(C=C4)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BEOH27	3-(Butyl-4-{4-[((2R)-2-hydroxy-2-{4-hydroxy-3-[(methylsulfonyl)amino]phenyl}-ethyl)amino]-1-piperidineyl}anilino)-3-oxopropanoic acid	Investigative	10076548	C27H38N4O7S	562.7	CCCCN(C1=CC=C(C=C1)N2CCC(CC2)NC[C@@H](C3=CC(=C(C=C3)O)NS(=O)(=O)C)O)C(=O)CC(=O)O	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BEU0S5	5-[(R)-1-Hydroxy-2-[[(alphaR)-alpha-isopropyl-4-methoxyphenethyl]amino]ethyl]resorcinol	Investigative	73056759	C20H27NO4	345.4	CC(C)[C@@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=CC(=C2)O)O)O	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BEXK08	2-(4,6-Dimethylpyridin-2-yl)-N-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]acetamide	Investigative	44574722	C26H31N3O3	433.5	CC1=CC(=NC(=C1)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O)C	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BF3D0G	4-[4-(4-Hexyl-phenyl)-thiazol-2-yl]-N-{4-[2-((R)-2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-benzenesulfonamide	Investigative	44301617	C36H40N4O3S2	640.9	CCCCCCC1=CC=C(C=C1)C2=CSC(=N2)C3=CC=C(C=C3)S(=O)(=O)NC4=CC=C(C=C4)CCNC[C@@H](C5=CN=CC=C5)O	IC50 = 90000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BFZ29M	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(2-phenylethyl)thiourea;hydrochloride	Investigative	49861305	C26H32ClN3O2S	486.1	C1=CC=C(C=C1)CCNC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BG35KW	4-{(S)-3-[1-(3,4-Dimethoxy-benzenesulfonyl)-piperidin-4-ylamino]-2-hydroxy-propoxy}-1,3-dihydro-benzoimidazol-2-one	Investigative	10278987	C23H30N4O7S	506.6	COC1=C(C=C(C=C1)S(=O)(=O)N2CCC(CC2)NC[C@@H](COC3=CC=CC4=C3NC(=O)N4)O)OC	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BG72XR	N-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-2-(1H-imidazol-2-yl)acetamide	Investigative	44574758	C22H26N4O3	394.5	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=NC=CN3)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BGF94Z	Chembl4202968	Investigative	145977755	C16H16N2O2S	300.4	C1=COC(=C1)C(CO)NCC2=CC=C(C=C2)C3=NC=CS3	Ki = 95400 nM	Poor binder
T52522	Adrenergic receptor beta-2	BH1E7K	Chembl4174295	Investigative	145949554	C22H32ClN3O5S	486	CC(C)(C)NCC(COC1=CC=C(C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BH6P4G	5-[(S)-1-Hydroxy-2-(4-methoxyphenethylamino)ethyl]resorcinol	Investigative	73057083	C17H21NO4	303.35	COC1=CC=C(C=C1)CCNC[C@H](C2=CC(=CC(=C2)O)O)O	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BHG19T	N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[5-(4-oxo-pentyl)-[1,2,4]oxadiazol-3-yl]-benzenesulfonamide	Investigative	12043159	C28H31N5O5S	549.6	CC(=O)CCCC1=NC(=NO1)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	IC50 = 57000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BI51PN	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(4-sulfamoylphenyl)thiourea;hydrochloride	Investigative	49861308	C24H29ClN4O4S2	537.1	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=C(C=C3)S(=O)(=O)N)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BI6MN1	2-(1-Benzylimidazol-2-yl)-N-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]propyl]phenyl]acetamide	Investigative	44219641	C30H34N4O3	498.6	CC(CC1=CC=C(C=C1)NC(=O)CC2=NC=CN2CC3=CC=CC=C3)NC[C@@H](COC4=CC=CC=C4)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BI7BA3	4-[1-Hydroxy-2-[2-[4-[2-[[2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl]amino]ethyl]phenyl]ethylamino]ethyl]-2-(hydroxymethyl)phenol	Investigative	57400044	C28H36N2O6	496.6	C1=CC(=CC=C1CCNCC(C2=CC(=C(C=C2)O)CO)O)CCNCC(C3=CC(=C(C=C3)O)CO)O	IC50 = 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BJ1S8F	4-[4-[[(Betar)-beta,4-Dihydroxy-3-(methylsulfonylamino)phenethyl]amino]piperidino]benzoic acid	Investigative	9803765	C21H27N3O6S	449.5	CS(=O)(=O)NC1=C(C=CC(=C1)[C@H](CNC2CCN(CC2)C3=CC=C(C=C3)C(=O)O)O)O	EC50 ~ 50000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BJ2P6G	Phenyl N-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]carbamate;hydrochloride	Investigative	49861309	C24H27ClN2O4	442.9	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=O)OC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BJN8E6	3-[2-[4-(2-Chlorophenyl)-1-piperazinyl]ethyl]-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione	Investigative	15054191	C22H22ClN5O2	423.9	C1CN(CCN1CCN2C(=O)C3=C(C4=CC=CC=C4N3)NC2=O)C5=CC=CC=C5Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BJZI84	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-pyrimidin-2-ylacetamide	Investigative	44127169	C23H26N4O4	422.5	C1=CN=C(N=C1)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=C(C=C3)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BK63UR	2-[1-[(4-Chlorophenyl)methyl]imidazol-2-yl]-N-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]acetamide	Investigative	44574827	C29H31ClN4O3	519	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=NC=CN3CC4=CC=C(C=C4)Cl)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BK7J1N	N-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]benzamide;hydrochloride	Investigative	49861313	C24H27ClN2O3	426.9	C1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BK81UH	N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[3-(4-methoxy-butyl)-2-oxo-imidazolidin-1-yl]-benzenesulfonamide	Investigative	44377665	C29H37N5O5S	567.7	COCCCCN1CCN(C1=O)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)CCNC[C@@H](C4=CN=CC=C4)O	IC50 = 50000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BK8EH2	Chembl4166379	Investigative	145956144	C25H30ClN3O5S	520	C1=CC=C(C=C1)CNCC(COC2=CC=C(C=C2)C(=O)NCCC3=CC=C(C=C3)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BKER74	2-[4-[4-[[(R)-beta,4-Dihydroxy-3-(methylsulfonylamino)phenethyl]amino]piperidino]benzyl]tetrahydro-1,2,4-oxadiazole-3,5-dione	Investigative	9827999	C23H29N5O7S	519.6	CS(=O)(=O)NC1=C(C=CC(=C1)[C@H](CNC2CCN(CC2)C3=CC=C(C=C3)CN4C(=O)NC(=O)O4)O)O	Ki = 74000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BL4H3S	4-(4-Benzo[b]thiophen-2-yl-thiazol-2-yl)-N-{4-[2-((R)-2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-benzenesulfonamide	Investigative	44301881	C32H28N4O3S3	612.8	C1=CC=C2C(=C1)C=C(S2)C3=CSC(=N3)C4=CC=C(C=C4)S(=O)(=O)NC5=CC=C(C=C5)CCNC[C@@H](C6=CN=CC=C6)O	IC50 = 93000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BL8FA4	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-isoquinolin-3-ylacetamide	Investigative	44127678	C28H29N3O4	471.5	C1=CC=C2C=NC(=CC2=C1)CC(=O)NC3=CC=C(C=C3)CCNC[C@@H](COC4=CC=C(C=C4)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BLBJ01	Chembl4160295	Investigative	145958632	C10H17ClN2O4S	296.77	CNCC(COC1=CC=C(C=C1)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BLBR70	N-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-2-(3-methylpyridin-2-yl)acetamide	Investigative	44574721	C25H29N3O3	419.5	CC1=C(N=CC=C1)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BLF5O1	(S)-N-(4-(2-(2-Hydroxy-3-(4-hydroxyphenoxy)propylamino)ethyl)phenyl)-2-(pyridin-2-yl)acetamide	Investigative	44127171	C24H27N3O4	421.5	C1=CC=NC(=C1)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=C(C=C3)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BM74IF	2-(1-Benzylbenzimidazol-2-yl)-N-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]acetamide	Investigative	44574825	C33H34N4O3	534.6	C1=CC=C(C=C1)CN2C3=CC=CC=C3N=C2CC(=O)NC4=CC=C(C=C4)CCNC[C@@H](COC5=CC=CC=C5)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BM7I6B	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-(3-methoxyphenyl)acetamide	Investigative	44127481	C26H30N2O5	450.5	COC1=CC=CC(=C1)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=C(C=C3)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BN3S0W	2-(1-Benzylimidazol-2-yl)-N-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]acetamide	Investigative	44219629	C29H32N4O3	484.6	C1=CC=C(C=C1)CN2C=CN=C2CC(=O)NC3=CC=C(C=C3)CCNC[C@@H](COC4=CC=CC=C4)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BNJ9Z8	Chembl4218602	Investigative	43634116	C18H19ClFN	303.8	CC(C1=CC=C(C=C1)Cl)NC2CC(C2)C3=CC=C(C=C3)F	Ki = 74000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BNSY10	Chembl4175397	Investigative	145950880	C22H30ClN3O6S	500	C1COCCN1CC(COC2=CC=C(C=C2)C(=O)NCCC3=CC=C(C=C3)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BOKH47	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-thiophen-2-ylacetamide	Investigative	44127575	C23H26N2O4S	426.5	C1=CSC(=C1)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=C(C=C3)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BP9SR7	2-(1-Benzylimidazol-2-yl)-N-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-N-propylacetamide	Investigative	44574913	C32H38N4O3	526.7	CCCN(C1=CC=C(C=C1)CCNC[C@@H](COC2=CC=CC=C2)O)C(=O)CC3=NC=CN3CC4=CC=CC=C4	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BPX34K	3-[2-[4-(4-Chlorophenyl)-1-piperazinyl]ethyl]-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione	Investigative	15054192	C22H22ClN5O2	423.9	C1CN(CCN1CCN2C(=O)C3=C(C4=CC=CC=C4N3)NC2=O)C5=CC=C(C=C5)Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BQ3Y4R	(4-(Pyrimidin-2-yl)phenyl)methanamine	Investigative	24229559	C11H11N3	185.22	C1=CN=C(N=C1)C2=CC=C(C=C2)CN	Ki = 78100 nM	Poor binder
T52522	Adrenergic receptor beta-2	BS4N5F	4-[(S)-2-Hydroxy-3-[1-(4-methoxyphenylsulfonyl)-4-piperidinylamino]propoxy]-9H-carbazole	Investigative	10301101	C27H31N3O5S	509.6	COC1=CC=C(C=C1)S(=O)(=O)N2CCC(CC2)NC[C@@H](COC3=CC=CC4=C3C5=CC=CC=C5N4)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BSO57M	7-Dipropylamino-5,6,7,8-tetrahydro-naphthalen-2-ol	Investigative	6603867	C16H25NO	247.38	CCCN(CCC)[C@@H]1CCC2=C(C1)C=C(C=C2)O	Ki = 86000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BSWB94	(2S)-1-[2-(4-Anilinophenyl)ethylamino]-3-phenoxypropan-2-ol;hydrochloride	Investigative	49861321	C23H27ClN2O2	398.9	C1=CC=C(C=C1)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BT2DA5	1-Cyano-2-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-phenylguanidine;hydrochloride	Investigative	49861322	C25H28ClN5O2	466	C1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O)NC#N.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BTC80S	2-(6-Chloropyridin-2-yl)-N-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]acetamide	Investigative	44574723	C24H26ClN3O3	439.9	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=NC(=CC=C3)Cl)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BTS3R9	2-[1-[(4-Bromophenyl)methyl]imidazol-2-yl]-N-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]acetamide	Investigative	44574867	C29H31BrN4O3	563.5	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=NC=CN3CC4=CC=C(C=C4)Br)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BTUJ56	Chembl4167532	Investigative	145955012	C20H28ClN3O6S	474	C1=CC(=CC=C1CCNC(=O)C2=CC=C(C=C2)OCC(CNCCO)O)S(=O)(=O)N.Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BTZ56V	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(4-methoxyphenyl)thiourea;hydrochloride	Investigative	44517695	C25H30ClN3O3S	488	COC1=CC=C(C=C1)NC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BU31SB	Chembl4174691	Investigative	145952345	C19H26ClN3O5S	443.9	CNCC(COC1=CC=C(C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BU42KJ	N-[4-[2-[[(2R)-2-Hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]propane-2-sulfonamide	Investigative	44335844	C18H25N3O3S	363.5	CC(C)S(=O)(=O)NC1=CC=C(C=C1)CCNC[C@@H](C2=CN=CC=C2)O	IC50 = 50000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BU63KD	N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[2-oxo-3-(3-oxo-3-pyrrolidin-1-yl-propyl)-imidazolidin-1-yl]-benzenesulfonamide	Investigative	44461488	C31H38N6O5S	606.7	C1CCN(C1)C(=O)CCN2CCN(C2=O)C3=CC=C(C=C3)S(=O)(=O)NC4=CC=C(C=C4)CCNC[C@@H](C5=CN=CC=C5)O	IC50 = 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BUHN63	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(4-methylphenyl)thiourea;hydrochloride	Investigative	49861316	C25H30ClN3O2S	472	CC1=CC=C(C=C1)NC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BVZQ62	1-(4-Bromophenyl)-3-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]thiourea;hydrochloride	Investigative	49861314	C24H27BrClN3O2S	536.9	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=S)NC3=CC=C(C=C3)Br)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BW19NX	Chembl4162920	Investigative	145958250	C22H32ClN3O5S	486	CCC(C)NCC(COC1=CC=C(C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BW5CT2	Chembl4170536	Investigative	145956073	C17H23ClN2O4S	386.9	CNCC(COC1=CC=C(C=C1)S(=O)(=O)NCC2=CC=CC=C2)O.Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BWM03V	Chembl4167473	Investigative	145956164	C20H28ClN3O5S	458	CCNCC(COC1=CC=C(C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BWO9S2	1-Benzyl-3-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]thiourea;hydrochloride	Investigative	49861323	C25H30ClN3O2S	472	C1=CC=C(C=C1)CNC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BWY2S7	N-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-2-[1-(naphthalen-2-ylmethyl)imidazol-2-yl]acetamide	Investigative	44574868	C33H34N4O3	534.6	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=NC=CN3CC4=CC5=CC=CC=C5C=C4)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BX14NK	4-{(S)-2-Hydroxy-3-[1-(4-methoxy-benzenesulfonyl)-piperidin-4-ylamino]-propoxy}-1,3-dihydro-benzoimidazol-2-one	Investigative	10140428	C22H28N4O6S	476.5	COC1=CC=C(C=C1)S(=O)(=O)N2CCC(CC2)NC[C@@H](COC3=CC=CC4=C3NC(=O)N4)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BY7HF8	Chembl4170908	Investigative	145950894	C24H36ClN3O5S	514.1	CC(C)N(CC(COC1=CC=C(C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)O)C(C)C.Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BY7M5R	N-{4-[2-((R)-2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[4-(1H-indol-3-yl)-thiazol-2-yl]-benzenesulfonamide	Investigative	44302005	C32H29N5O3S2	595.7	C1=CC=C2C(=C1)C(=CN2)C3=CSC(=N3)C4=CC=C(C=C4)S(=O)(=O)NC5=CC=C(C=C5)CCNC[C@@H](C6=CN=CC=C6)O	IC50 = 50000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BYG12C	(S)-N-(4-(2-(2-Hydroxy-3-phenoxypropylamino)ethyl)phenyl)benzenesulfonamide	Investigative	45269853	C23H26N2O4S	426.5	C1=CC=C(C=C1)OC[C@H](CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=CC=C3)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BYGD71	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]benzenesulfonamide	Investigative	9933039	C23H26N2O5S	442.5	C1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=C(C=C3)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BYJZ36	Chembl4170860	Investigative	145949377	C21H30ClN3O5S	472	CC(C)NCC(COC1=CC=C(C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N)O.Cl	Ki ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BYV61Z	2-(Hydroxymethyl)-4-[1-hydroxy-2-[2-[4-[4-(3-phenylpropyl)piperidin-1-yl]phenyl]ethylamino]ethyl]phenol	Investigative	90644147	C31H40N2O3	488.7	C1CN(CCC1CCCC2=CC=CC=C2)C3=CC=C(C=C3)CCNCC(C4=CC(=C(C=C4)O)CO)O	Ki = 199526.23 nM	Poor binder
T52522	Adrenergic receptor beta-2	BYZ74L	2-(1-Benzylimidazol-2-yl)-N-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-N-methylacetamide	Investigative	44219630	C30H34N4O3	498.6	CN(C1=CC=C(C=C1)CCNC[C@@H](COC2=CC=CC=C2)O)C(=O)CC3=NC=CN3CC4=CC=CC=C4	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BZ30OJ	N-[4-[2-[[(2S)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-2-pyridin-3-ylacetamide	Investigative	44127167	C24H27N3O4	421.5	C1=CC(=CN=C1)CC(=O)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=C(C=C3)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BZ54BW	4-[(S)-2-Hydroxy-3-[1-(4-methoxyphenylsulfonyl)-4-piperidinylamino]propoxy]phenol	Investigative	44309649	C21H28N2O6S	436.5	COC1=CC=C(C=C1)S(=O)(=O)N2CCC(CC2)NC[C@@H](COC3=CC=C(C=C3)O)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BZL05F	1-[4-[2-[[(2S)-2-Hydroxy-3-phenoxypropyl]amino]ethyl]phenyl]-3-(3-methoxyphenyl)thiourea;hydrochloride	Investigative	44517693	C25H30ClN3O3S	488	COC1=CC=CC(=C1)NC(=S)NC2=CC=C(C=C2)CCNC[C@@H](COC3=CC=CC=C3)O.Cl	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	BZY43W	(S)-1-[1-(4-Butoxy-benzenesulfonyl)-piperidin-4-ylamino]-3-(9H-carbazol-4-yloxy)-propan-2-ol	Investigative	10144004	C30H37N3O5S	551.7	CCCCOC1=CC=C(C=C1)S(=O)(=O)N2CCC(CC2)NC[C@@H](COC3=CC=CC4=C3C5=CC=CC=C5N4)O	EC50 ~ 100000 nM	Poor binder
T52522	Adrenergic receptor beta-2	D04BYL	6-fluoronorepinehprine	Investigative	10352428	C8H10FNO3	187.17	C1=CC(=C(C(=C1[C@H](CN)O)F)O)O	Ki = 70100 nM	Poor binder
T52522	Adrenergic receptor beta-2	D0H2WQ	QUINPIROLE	Investigative	54562	C13H21N3	219.33	CCCN1CCC[C@H]2[C@H]1CC3=C(C2)NN=C3	Ki = 100000 nM	Poor binder